LRRK2-IN-17
LRRK2-IN-17 (Compound 6) is an orally active LRRK2 inhibitor (IC50: 3.5 and 3.3 nM for WT and G2019S, respectively). LRRK2-IN-17 inhibits RET kinase (IC50: 59 nM). LRRK2-IN-17 can be used in cancer and Parkinson's disease (PD) research.
For research use only. We do not sell to patients.
- CAS No.: 2101821-86-5
- Formula: C18H18N8
- Molecular Weight:346.39
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
CAS No. 2101821-86-5
-
Molecular Weight 346.39
-
Formula C18H18N8
-
SMILES
CN1C=C(NC2=NC(N[C@@H]3C4=C(C=CC=C4)CC3)=C5C=CNC5=N2)N=N1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)